Allergan Hits Lupin With 2nd Eye Drop Patent Suit
Allergan Inc. and two Japanese pharmaceutical companies sued Lupin Ltd. in Delaware on Wednesday to stop the company's proposed generic version of pinkeye treatment Zymar, following a similar suit to halt...To view the full article, register now.
Already a subscriber? Click here to view full article